Skip to main content
Caplight Logo









AgeRate

AgeRate

Private
HamiltonHealthcare & Life Scienceshttps://agerate.com

Company Overview

AgeRate operates in Healthcare & Life Sciences and is based in Hamilton. It was founded in 2018.

AgeRate is a biotechnology company that provides at-home epigenetic testing and a mobile app to help users track biological age and receive personalized lifestyle recommendations for longevity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce, Precision Medicine

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AgeRate Comparables

Compare AgeRate with similar companies based on industry and business-model similarity.

AgeRate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Muhdo Health
86%
epiAge Deutschland UG
81%
NOVOS
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AgeRate Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for AgeRate. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kevin Peters

Co-Founder, Chief Technology Officer

Founding Team

Cole Kirschner

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

AgeRate Filings

Explore SEC and related filing metadata, where available.

AgeRate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AgeRate's valuation, stock price, and market status.

Is AgeRate a public or private company?

AgeRate is a private company.

What is the current stock price of AgeRate?

AgeRate is a private company, so its shares have no public market price. Caplight tracks AgeRate's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AgeRate worth (valuation)?

Valuation information for AgeRate is not publicly available.

Can I buy AgeRate stock?

AgeRate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AgeRate's last funding round?

Funding round information for AgeRate is not publicly available.

Who are the main investors in AgeRate?

Investor information for AgeRate is not publicly disclosed.

Will AgeRate IPO soon?

No public IPO plans have been announced for AgeRate.

How can I track AgeRate secondary market activity?

Caplight tracks bids, offers, and trades in AgeRate's shares on secondary markets.

Firmographic Details

HeadquartersHamilton
Employee Range4
Year Founded2018
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?